CHIMERIC ANTIGEN RECEPTOR T CELLS DERIVED FROM IMMUNOENGINEERED PLURIPOTENT STEM CELLS

The invention provides universally acceptable "off-the-shelf" hypoimmune pluripotent (HIP) cells and hypoimmune chimeric antigen receptor T (CAR-T) cells derived from the HIP cells. The engineered therapeutic cells can be administered to subjects as an adoptive cell-based immunotherapy to...

Full description

Saved in:
Bibliographic Details
Main Authors DEUSE TOBIAS, SCHREPFER SONJA
Format Patent
LanguageChinese
English
Published 09.04.2021
Subjects
Online AccessGet full text

Cover

Loading…